This follows the initial licence for treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC) in 2020. Following entry into a commercial agreement with Bayer ...

‘We know that if you're black or from a working class area, you're more likely to get an incurable prostate cancer diagnosis and less likely to get the best treatments on the NHS. ‘We're ...

We know that if you're black or from a working class area, you're more likely to get an incurable prostate cancer diagnosis and less likely to get the best treatments on the NHS. 'We're reaching ...

All men at high risk of prostate cancer should be offered checks even if it costs the NHS more to deliver it ... early improves the odds of successful treatment. The Daily Mail is campaigning ...

People with prostate cancer often face the unenviable task of deciding between treatments with side-effects that can profoundly affect their lives. They rely on health professionals to support them ...